
|Articles|September 1, 2006
Eye on Washington
Author(s)Judith Asch-Goodkin
Advertisement
In September, Congress returns, rarin' to go, from its August recess. Time is short until midterm elections, and the two houses have much unfinished business to get to in time to impress voters. Still unresolved when members adjourned was legislation to reform lobbying practices, regulate immigration, and pass the spending bills that fund the operations of government.
Advertisement
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA grants GEn-1123 rare disease designations for Duchenne muscular dystrophy
2
New sunscreen ingredient clears FDA for the first time since the 1990s
3
FDA accepts vedolizumab sBLA for pediatric ulcerative colitis and Crohn's disease
4
FDA approves lebrikizumab every-8-week maintenance dosing for moderate-to-severe atopic dermatitis
5


